Structure–Activity Relationship Studies on Novel Antiviral Agents for Norovirus Infections
Human norovirus is the leading cause of acute gastroenteritis worldwide, affecting every year 685 million people. Norovirus outbreaks are associated with very significant economic losses, with an estimated societal cost of 60 billion USD per year. Despite this, no therapeutic options or vaccines are...
Main Authors: | Salvatore Ferla, Carmine Varricchio, William Knight, Pui Kei Ho, Fabiana Saporito, Beatrice Tropea, Giulio Fagan, Ben Matthew Flude, Federica Bevilacqua, Nanci Santos-Ferreira, Jana Van Dycke, Johan Neyts, Andrea Brancale, Joana Rocha-Pereira, Marcella Bassetto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/9/1795 |
Similar Items
-
Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase
by: Gilda Giancotti, et al.
Published: (2022-12-01) -
Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections
by: Nanci Santos-Ferreira, et al.
Published: (2021-07-01) -
Norovirus Protease Structure and Antivirals Development
by: Boyang Zhao, et al.
Published: (2021-10-01) -
Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
by: Geng-Hao Bai, et al.
Published: (2023-07-01) -
Corrigendum: Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review
by: Geng-Hao Bai, et al.
Published: (2023-12-01)